Genscript Biotech Corporation (FRA:G51)

Germany flag Germany · Delayed Price · Currency is EUR
1.342
-0.005 (-0.33%)
At close: Jan 30, 2026
3.99%
Market Cap3.03B +20.9%
Revenue (ttm)705.13M +63.2%
Net Income2.65B
EPS1.20
Shares Outn/a
PE Ratio1.14
Forward PE33.62
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume293
Open1.342
Previous Close1.346
Day's Range1.342 - 1.342
52-Week Range1.119 - 2.042
Betan/a
RSI35.59
Earnings DateMar 10, 2026

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, pept... [Read more]

Industry Commercial Physical and Biological Research
Founded 2002
Employees 5,769
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol G51
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements